Chinese Approval? Should China approve the HB4 soybean for import it will be a substantial catalyst for Verdeca, RKDA and BIOX.

HB4 Soy is approved for cultivation and commercialization in the United States, Canada, Brazil, Argentina and Paraguay, which together represent about 85% of the global soybean market.

The HB4 stack is Verdeca's newest product release from its pipeline of traits developed to benefit soybean producers through quality improvement, stress mitigation and management practices.

The HB4 trait – developed by Verdeca LLC, a soybean technology joint venture between Bioceres and Arcadia – enables plants to adapt to multiple environmental stresses and achieve higher yields.

HB4 Soy EBITDA target for fiscal year 2025 at $20-25 million. Total addressable market estimated at an aggregate of 35 million hectares for the top three soybean markets, Argentina, Brazil and the ...

Davis-based Arcadia (Nasdaq: RKDA) is part of a joint venture developing the trait for stress-tolerant soybeans. Field trials of the new soybean trait, called HB4, show 14 percent greater yield ...

Waiting for FY25 HB4 soy: The company had commented in 2Q24 that it expected to launch HB4 soy varieties commercially in Brazil and other markets in FY25 (currently in the seed multiplication phase).

• HB4 soy: Approximately 23,000 hectares of drought-tolerant HB4 soybeans were planted (up from 3,000 hectares last year) with the number of growers increasing from 15 to 148.

These HB4 soybean varieties, which are still in a pre-commercial stage, provide tolerance to droughts and herbicides.

"HB4 is a novel soybean trait that enhances the traditional herbicide tolerance package to provide yield stability across diverse environments," said Verdeca General Manager Martin Mariani Ventura.

In late-April, Ministry of Agriculture of China granted approval for the importation of HB4 Soy for animal and for human consumption. Bioceres has been growing seed inventories for HB4 Soy in ...